文献速递白血病

内源性前列腺素J2激活PPARγ介导硒在小鼠白血病中的抗白血病效应

Activation of PPARγ by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia.
PubMed 文献 · Blood · 2017-01-23

在小鼠慢性粒细胞白血病(CML)模型中,补充无毒剂量硒元素可通过内源性环戊烯酮前列腺素(CyPGs)Δ12-PGJ2和15d-PGJ2激活核激素受体PPARγ,降低Stat5表达并下调Cited2,从而消除白血病干细胞、缓解CML症状;PPARγ拮抗剂GW9662阻断该效应,而PPARγ激动剂吡格列酮可模拟硒的作用。

要点

  • 硒补充的抗白血病效应依赖内源性CyPGs(Δ12-PGJ2和15d-PGJ2)激活PPARγ。
  • PPARγ拮抗剂GW9662通过显著减少CyPGs阻断硒的抗白血病效应。
  • 吡格列酮模拟硒补充,降低15-Pgdh活性、增加CyPG水平并抑制CML进展。

核心结论

  • 硒补充通过内源性CyPGs激活PPARγ,降低Stat5表达并下调Cited2,从而消除白血病干细胞并缓解CML症状。
  • 这些研究提示硒补充可能作为CML的辅助治疗。

研究设计与样本

  • 研究为小鼠白血病模型研究,小鼠接受补充硒的饮食。
  • 研究使用PPARγ拮抗剂GW9662和PPARγ激动剂吡格列酮进行干预。

主要发现

  • 硒补充的抗白血病效应依赖内源性CyPGs(Δ12-PGJ2和15d-PGJ2)的产生。
  • GW9662通过显著减少CyPGs阻断硒补充的抗白血病效应,该效应由15-Pgdh活性增加介导,15-Pgdh氧化并灭活Δ12-PGJ2和15d-PGJ2。
  • 吡格列酮治疗降低15-Pgdh活性并增加CyPG水平,抑制CML进展。
  • 硒依赖的PPARγ激活降低Stat5表达,导致Cited2下调,Cited2是LSC静息的主要调节因子。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Supplementation with nontoxic doses of micronutrient selenium has been shown to alleviate chronic myelogenous leukemia (CML) via the elimination of leukemia stem cells (LSCs) in mice. This treatment provides a new and novel method for eliminating the LSCs that are otherwise not targeted by existing therapies. The antileukemic effect of selenium was dependent on the production of endogenous cyclopentenone prostaglandins (CyPGs), Δ-12 prostaglandin J2 (Δ12-PGJ2), and 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2). Here, we show that these endogenous CyPGs, produced by mice maintained on selenium-supplemented diets, alleviate the symptoms of CML through their ability to activate the nuclear hormone receptor, peroxisome proliferator activated receptor γ (PPARγ). GW9662, a potent PPARγ antagonist, blocked the antileukemic effect of selenium supplementation by significantly reducing CyPGs. This effect was mediated by an increase in 15-prostaglandin dehydrogenase (15-Pgdh) activity, which oxidizes and inactivates Δ12-PGJ2 and 15d-PGJ2 In contrast, treatment with the PPARγ agonist pioglitazone mimicked selenium supplementation. This treatment led to decreased 15-Pgdh activity and increased CyPG levels, which inhibited CML progression. Selenium-dependent activation of PPARγ mediated by endogenous CyPGs decreased Stat5 expression leading to the downregulation of Cited2, a master regulator of LSC quiescence. These studies suggest a potential role for selenium supplementation as an adjuvant therapy in CML.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Finch ER, Tukaramrao DB, Goodfield LL, et al. Activation of PPARγ by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia. Blood. 2017. PMID: 28115365. doi:10.1182/blood-2016-08-736405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。